Here's Why Hold Strategy is Apt for ITT Stock Right Now

ITT Inc. ITT is poised to gain from strength in the end markets like chemical and industrial pumps, commercial aerospace and defense, rail and general industrial despite supply-chain constraints, high cost of sales (due to raw material cost inflation) and increasing operating expenses. The company’s organic orders grew 7% year over year in the third quarter, driven by strong demand for pumps, connectors, aerospace and defense components. Also, a robust backlog in its businesses, supported by the recovery in the energy end market, is expected to boost its performance in the long run.

ITT has been investing in product innovation across its connectors, friction technologies and pump businesses for some time now. ITT also launched the third generation of its i-ALERT Condition Monitoring Solution in May 2022. Also, its connector business unveiled its ruggedized, modular circular series Veam MOVE-MOD in November 2021. The company intends to become more competent on the back of innovation investments in the quarters ahead.

ITT acquired Clippard Instrument Laboratories’ product lines in August 2022. The buyout expanded its Compact Automation product offering in the robotics, packaging and automation end markets. The acquisition of CRP Technology and CRP USA (jointly CRP) in June 2022 helped ITT acquire additive manufacturing technology capabilities and strengthened its position in the material science space. Also, the buyout of Habonim (April 2022) boosted ITT’s offerings in the cryogenic and hydrogen ball valve space apart from expanding into new end markets. It predicts the buyout to be accretive to its EBITDA margin.

In the first nine months of 2022, ITT paid out dividends of $66.1 million and bought back shares worth $245.6 million. Also, the quarterly dividend rate was hiked 20% in February 2022.

In light of the above-mentioned positives, we believe, investors should hold on to the ITT stock for now, as suggested by its current Zacks Rank #3 (Hold). In the past six months, the stock has rallied 24% compared with the industry’s 6.1% increase.

Zacks Investment Research
Image Source: Zacks Investment Research

Stocks to Consider

Some better-ranked stocks are:

MRC Global Inc. MRC presently sports a Zacks Rank #1 (Strong Buy). MRC’s earnings surprise in the last four quarters was 103%, on average. You can see the complete list of today’s Zacks #1 Rank stocks.

In the past 60 days, MRC Global’s earnings estimates have increased 16.2% for 2022. The stock has gained 24.1% in the past six months.

Xylem Inc. XYL presently has a Zacks Rank #2 (Buy). XYL’s earnings surprise in the last four quarters was 13.3%, on average.

In the past 60 days, Xylem’s earnings estimates have increased 0.1% for 2022. The stock has gained 40.3% in the past six months.

EnerSys ENS delivered an average four-quarter earnings surprise of 2.1%. ENS presently carries a Zacks Rank of 2.

ENS’ earnings estimates have increased 0.6% for fiscal 2023 in the past 60 days. The stock has gained 23.2% in the past six months.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ITT Inc. (ITT) : Free Stock Analysis Report

MRC Global Inc. (MRC) : Free Stock Analysis Report

Enersys (ENS) : Free Stock Analysis Report

Xylem Inc. (XYL) : Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.